REQUEST A DEMO
Total
USD $0.00
Search more companies

Orion Pharma (My) Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Orion Pharma (My) Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Orion Pharma (My) Sdn. Bhd. is a company based in Malaysia, with its head office in Kuala Lumpur. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Orion Pharma (My) Sdn. Bhd. was incorporated on January 31, 2020. There was a net sales revenue increase of 12.69% reported in Orion Pharma (My) Sdn. Bhd.’s latest financial highlights for 2022. Over the same period, its total assets grew by 23.14%. In 2022, Orion Pharma (My) Sdn. Bhd.’s net profit margin decreased by 13.93%.

Headquarters
E-20-01, Menara Suezcap 2, Kl Gateway, No. 2, Jalan Kerinchi, Gerbang Kerinchi Lestari
Kuala Lumpur; Federal Territories; Postal Code: 59200

Contact Details: Purchase the Orion Pharma (My) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Orion Pharma (My) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Orion Pharma (My) Sdn. Bhd. report to view the information.
Incorporation Date:
January 31, 2020
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Orion Pharma (My) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
12.69%
Total operating revenue
12.69%
Operating profit (EBIT)
-80.48%
EBITDA
-78.39%
Net Profit (Loss) for the Period
-76.88%
Total assets
23.14%
Total equity
20.23%
Operating Profit Margin (ROS)
-18.96%
Net Profit Margin
-13.93%
Return on Equity (ROE)
-70.66%
Debt to Equity Ratio
1.83%
Quick Ratio
-0.01%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?